Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6515
    +0.0015 (+0.23%)
     
  • OIL

    83.05
    +0.24 (+0.29%)
     
  • GOLD

    2,332.80
    -5.60 (-0.24%)
     
  • Bitcoin AUD

    98,731.69
    -3,881.38 (-3.78%)
     
  • CMC Crypto 200

    1,390.29
    +7.71 (+0.56%)
     
  • AUD/EUR

    0.6079
    +0.0009 (+0.14%)
     
  • AUD/NZD

    1.0947
    +0.0005 (+0.05%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,080.64
    +40.26 (+0.50%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,031.13
    -57.57 (-0.32%)
     
  • Hang Seng

    17,300.95
    +99.68 (+0.58%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why Healthcare Could Be a Make-or-Break Strategy for Walgreens

Why Healthcare Could Be a Make-or-Break Strategy for Walgreens

Walgreens Boots Alliance (NASDAQ: WBA) has made for a disappointing investment to hold over the past five years. While Walgreens does offer a high yield of 4.6%, that may be of little comfort to investors who have incurred such significant losses. Whether the next five years will be any better for the stock will likely depend on the company's healthcare strategy.